Buprenorphine to Improve HIV Care Engagement and Outcomes

NCT01936857 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

281

Enrollment

OTHER

Sponsor class

Conditions

HIV
Substance Related Disorders

Interventions

DRUG: Buprenorphine/naloxone
DRUG: Methadone Maintenance Therapy

Sponsor

Oregon Health and Science University

Collaborators

[object Object]
[object Object]